LJ
Leon O Moulder Jr (See Remarks) filed 5 Form 4 reports in the trailing twelve months (5 purchases, 0 sales), most often in Zenas BioPharma, Inc. (ZBIO). Across 5 priced purchase filings, the average 21-session return was +13.9% from execution and +14.7% from disclosure (delay-adjusted; derived). The largest single filing was $1.6M of ZBIO (100,000 sh across 3 lots, as filed), executed Jan 7. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+13.9%
avg across 5 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+14.7%
same 5 filings, from disclosure
Filings, ttm
5
5 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.8M
shares × price, as filed
Last traded
May 18
Filed May 18
Impact on $10,000 · 12M
$15,154 (+51.5%)
S&P 500 $10,907 (+9.1%) · 42.5 pts ahead
Leon O Moulder Jr
S&P 500
Derived: compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $7.4M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
ZBIORecent filings
ZBIOPURCHASE
Zenas BioPharma, Inc.
View filing →
$112K7,500 sh × $15.00
Exec Nov 18 2024
Filed Nov 20 2024 · 5:30 PM ET